What is SLU-PP-332?
Research Focus: Metabolic, Appetite
SLU-PP-332 is a non-peptide small molecule that acts as a selective agonist of the Estrogen Receptor Beta (ERβ). It is studied for its potential to improve metabolic health and muscle function.
At a Glance
ERβ is highly expressed in skeletal muscle and adipose tissue. Activation of ERβ is believed to promote mitochondrial biogenesis and improve glucose and lipid metabolism, often mimicking the effects of exercise. This section provides a general overview of its research context.
About SLU-PP-332
ERβ is highly expressed in skeletal muscle and adipose tissue. Activation of ERβ is believed to promote mitochondrial biogenesis and improve glucose and lipid metabolism, often mimicking the effects of exercise.
How It Works
ERβ Activation
Selectively targets Estrogen Receptor Beta, avoiding the unwanted side effects associated with Estrogen Receptor Alpha (ERα) activation.
Mitochondrial Biogenesis
Promotes the creation of new mitochondria, enhancing the muscle's capacity to burn fat and glucose.
Current Research Insights
Skeletal Muscle Metabolism
Researchers are interested in SLU-PP-332 as a potential 'exercise mimetic' that could improve muscle health and metabolic function without intense physical activity.
Areas of Study
Metabolic Syndrome
Investigated for improving insulin sensitivity and lipid profiles.
Muscle Function and Endurance
Studied for enhancing muscle performance and combating age-related muscle decline.
SLU-PP-332 is strictly intended for laboratory and clinical research:
- Available exclusively from authorized research suppliers
- Not FDA-approved for general therapeutic use
- Comprehensive safety, efficacy, and dosage guidelines remain under ongoing investigation
FAQs
Research
- Studies on selective Estrogen Receptor Beta agonists and their effects on skeletal muscle.
- Research into SLU-PP-332's role in mitochondrial function and metabolism.
(The above references are representative and support the research context of this peptide, GLP hormone or regenerative therapy. All claims are for research purposes only and do not imply approved medical use.)